Source: Monitor Mercantil, 27/08/2007

The complaint was made by the Chamber of Medicines of the Brazilian Institute of Ethics in Competition (Etco). The chamber gathers the large industries, responsible for 70% of the sector's production, and lists other numbers: with tax evasion it would be possible to increase spending on hospitalizations by the Ministry of Health by 50%; expand the distribution of medicines by the Unified Health System (SUS) by 42%; and with the difference in price spent on similar drugs instead of official generics, it would be possible to increase the drug consumption potential of the poorest 50% by 20%.